Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Tetraphase Pharma (TTPH) Prices Larger 4.3M Common Offering at $35/Share
March 12, 2015 8:55 AM EDTTetraphase Pharma (NASDAQ: TTPH) announced the pricing of an underwritten public offering of 4,300,000 shares of common stock for a public offering price of $35.00 per share. The gross proceeds to Tetraphase from this offering are expected to be approximately $150.0 million, before deducting underwriting discounts and... More
Tetraphase Pharma (TTPH) Announces 3.5M Common Offering
March 9, 2015 4:51 PM EDTTetraphase Pharma (NASDAQ: TTPH) announced that it intends to offer and sell up to 3,500,000 shares of its common stock in an underwritten public offering. All of the shares of common stock to be sold in the offering will be offered by Tetraphase.
BMO... More
